219 related articles for article (PubMed ID: 33390842)
1. MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
Liu Y; Zhu C; Tang L; Chen Q; Guan N; Xu K; Guan X
Int J Biol Sci; 2021; 17(1):178-187. PubMed ID: 33390842
[TBL] [Abstract][Full Text] [Related]
2. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
[TBL] [Abstract][Full Text] [Related]
4. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
6. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
7. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
[TBL] [Abstract][Full Text] [Related]
8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
9. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
10. High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.
Gupta N; Jung K; Wu C; Alshareef A; Alqahtani H; Damaraju S; Mackey JR; Ghosh S; Sabri S; Abdulkarim BS; Bigras G; Lai R
Oncotarget; 2017 Apr; 8(17):28101-28115. PubMed ID: 28427212
[TBL] [Abstract][Full Text] [Related]
11. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
13. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
[TBL] [Abstract][Full Text] [Related]
14. Triterpene Acid (
Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
[TBL] [Abstract][Full Text] [Related]
15. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
[TBL] [Abstract][Full Text] [Related]
16. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
17. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.
Nair R; Roden DL; Teo WS; McFarland A; Junankar S; Ye S; Nguyen A; Yang J; Nikolic I; Hui M; Morey A; Shah J; Pfefferle AD; Usary J; Selinger C; Baker LA; Armstrong N; Cowley MJ; Naylor MJ; Ormandy CJ; Lakhani SR; Herschkowitz JI; Perou CM; Kaplan W; O'Toole SA; Swarbrick A
Oncogene; 2014 Jul; 33(30):3992-4002. PubMed ID: 24056965
[TBL] [Abstract][Full Text] [Related]
18. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y
Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313
[TBL] [Abstract][Full Text] [Related]
19. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
20. Cuproptosis engages in c-Myc-mediated breast cancer stemness.
Wang R; Xu K; Chen Q; Hu Q; Zhang J; Guan X
J Transl Med; 2023 Jun; 21(1):409. PubMed ID: 37353799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
